Please note that some translations using Google Translate may not be accurately represented, and image captions and downloaded documents cannot be translated. Dana-Farber assumes no liability for inaccuracies that may result for using this third-party tool, which is for website translation and not clinical interactions. You may request a live medical interpreter for a discussion about your care.
If you're living with metastatic breast cancer, view this video webchat from May 20, 2016, with experts Nancy Lin, MD, and Erica Mayer, MD, MPH, on choosing clinical trials. These research studies, which test new drugs in patients, can offer you advanced care and make new treatments possible in the future.
Dr. Lin is clinical director of the Breast Oncology Program at the Susan F. Smith Center for Women's Cancers at Dana-Farber, and Dr. Mayer is a senior physician. Participants submitted questions for Dr. Lin or Dr. Mayer by emailing webchats@dfci.harvard.edu or tweeting them to @DanaFarber using the hashtag #DFCIwebchat.
Learn more about metastatic breast cancer.
Appointments and Second Opinions
For adults: 877-442-3324For children: 888-733-4662
Video Webchat Series
Dana-Farber's Video Webchat Series features the latest in cancer news and information from top doctors and researchers as well as patients and caregivers. View our upcoming and previous webchat topics.